Re: News from a Chinese/Japenese Article about Zenith

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: News from a Chinese/Japenese Article about Zenith

posted on Oct 26, 2016 07:31PM

Hmmmmm, if this is legitimate news from a Japanese publication than I strongly feel Zenith IR should comment On what this article intention is, Talking about a phase 2 trial and a partner before a proper NR from management means shareholders are missing something?? I am going to send a email to management tomorrow

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply